Clinical Trial Analysis
Insights for "Acute Myeloid Leukemia (AML)"
Overview
Total Trials
416
All registered studies
Active Recruiting
149
35.8%
Currently enrolling patients
Completed
182
43.8%
Studies finished
Phase 3 Studies
11.3%
Advanced phase trials
Key Insights
Leading Region
USA
Most active geographical area
Top Organization
M.D. Anderson Cancer Center
Most active research sponsor
Distribution Analysis
Study Phases
Trial distribution by development phase
Phase 1
20148.3%
Phase 2
13432.2%
Phase 3
4711.3%
Not Applicable
204.8%
Early Phase 1
92.2%
Phase 4
51.2%
Phase 1
20148.3%
Phase 2
13432.2%
Phase 3
4711.3%
Not Applicable
204.8%
Early Phase 1
92.2%
Phase 4
51.2%
Recruitment Status
Current enrollment and completion status
Total: 465
Geographic & Sponsor Analysis
Geographic Distribution
Trial activity by country
Top Sponsors
Most active research organizations
Rank
Company
Count
1
M.D. Anderson Cancer Center
29
2
AbbVie
28
3
Astellas Pharma Global Development, Inc.
13
4
Novartis Pharmaceuticals
13
5
Daiichi Sankyo
9
6
University of Ulm
8
7
Celgene
7
8
Memorial Sloan Kettering Cancer Center
7
9
St. Jude Children's Research Hospital
7
10
French Innovative Leukemia Organisation
6
Medical Focus Areas
Medical Conditions
Most studied disease areas
Rank
Condition
Count
1
Acute Myeloid Leukemia (AML)
178
2
Acute Myeloid Leukemia
132
3
Leukemia, Myeloid, Acute
39
4
Myelodysplastic Syndrome (MDS)
31
5
Myelodysplastic Syndrome
28
6
Leukemia
26
7
Myelodysplastic Syndromes
19
8
AML
15
9
Acute Lymphoblastic Leukemia (ALL)
13
10
Chronic Myelomonocytic Leukemia (CMML)
10
Treatment Types
Most common interventions
Rank
Intervention
Count
1
Cytarabine
48
2
Venetoclax
42
3
Azacitidine
40
4
Fludarabine
23
5
Decitabine
17
6
Cyclophosphamide
15
7
Placebo
14
8
Idarubicin
13
9
Daunorubicin
10
10
Clofarabine
8